Susquehanna International Group, LLP Immatics N.V. Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Immatics N.V. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 15,291 shares of IMTX stock, worth $83,183. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,291
Previous 21,585
29.16%
Holding current value
$83,183
Previous $153,000
55.56%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding IMTX
# of Institutions
82Shares Held
91.5MCall Options Held
201KPut Options Held
109K-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.7MShares$79.8 Million0.04% of portfolio
-
Perceptive Advisors LLC New York, NY9.38MShares$51 Million1.77% of portfolio
-
Suvretta Capital Management, LLC New York, NY9.14MShares$49.7 Million1.8% of portfolio
-
Wellington Management Group LLP Boston, MA8.58MShares$46.7 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY7.28MShares$39.6 Million0.39% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $415M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...